The Interplay Between the Immune System and Cancer

Cancer is a complex disease that can arise from a variety of factors, including genetic mutations, environmental exposures, and lifestyle choices. While traditional treatments for cancer, such as chemotherapy and radiation therapy, have made significant strides in recent years, there is growing interest in harnessing the power of the immune system to both prevent and treat cancer.

How The Immune System Can Prevent the Development of Cancer?

The immune system plays a crucial role in preventing the development of cancer. One of the main mechanisms by which the immune system prevents cancer is through the detection and elimination of cancerous cells before they have a chance to grow and spread.

This is achieved through the action of immune cells such as T cells, which can recognize and target cancerous cells for destruction. Additionally, the immune system can help to prevent the development of cancer by identifying and eliminating cells that have undergone abnormal changes that could potentially lead to cancer. This process is known as immune surveillance, and it is thought to be a key factor in preventing the development of many types of cancer.

The Different Approaches To Immune System-Mediated Cancer Treatment

There are several different approaches to immune system-mediated cancer treatment, including:

1. Checkpoint inhibitors: These drugs block the proteins that cancer cells use to evade detection by the immune system, thereby promoting the destruction of cancer cells.
2. Adoptive cell transfer: This approach involves the extraction of immune cells from a patient's body, followed by genetic modification or other treatments to enhance their cancer-fighting capabilities. The modified cells are then reintroduced into the patient's body, where they can target and destroy cancer cells.
3. Cancer vaccines: These vaccines are designed to stimulate the immune system to recognize and attack cancer cells.
4. Oncolytic viruses: These are viruses that have been modified to selectively infect and destroy cancer cells.
5. Monoclonal antibodies: These are laboratory-produced molecules that can be designed to specifically target and bind to proteins on the surface of cancer cells, thereby promoting their destruction by the immune system.
6. Immune checkpoint blockade: This approach involves blocking the activity of specific molecules that are involved in immune system regulation, thereby promoting the activation of the immune system and the destruction of cancer cells.
7. T-cell therapy: This approach involves the isolation and genetic modification of T-cells, a type of immune cell, to enhance their ability to recognize and destroy cancer cells.
8. Immune system modulators: These drugs work by altering the activity of the immune system to promote the destruction of cancer cells.

How does the immune system fight cancer?

The immune system can also target cancer cells through the release of cytokines, which are signaling molecules that can stimulate the immune response and activate immune cells to attack cancer cells. While the immune system is capable of fighting cancer, it can sometimes be overwhelmed or outmaneuvered by cancer cells that are able to evade detection or suppress the immune response.

What is cancer of the immune system called?

Cancer of the immune system is called lymphoma. Lymphoma is a type of cancer that affects the cells of the immune system known as lymphocytes. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. These cancers can arise in the lymph nodes, bone marrow, and other organs and tissues of the body that contain lymphocytes. While lymphoma is a cancer of the immune system, most other types of cancer do not originate from immune cells.

Know more about :  Why non-GMO matters!

Reference: 

https://www.mskcc.org/news/immune-system-can-fight-cancer-so-why-doesn-t-it

https://link.springer.com/chapter/10.1007/978-94-009-4307-0_3

https://www.cancerresearchuk.org/about-cancer/what-is-cancer/body-systems-and-cancer/the-immune-system-and-cancer